Eli Lilly to invest $1 billion in India, expand manufacturing and introduce oral weight-loss drug

Eli Lilly is significantly expanding its Indian operations with over $1 billion in contract manufacturing investments and plans for a global capability center. The US pharma giant is positioning India as a key hub, preparing to introduce an oral version of its experimental weight loss drug orforglipron and a new manufacturing hub in Hyderabad.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zgTGPxw
via IFTTT

0 comments:

Post a Comment